GlassScriptPhysician profile
Donald I Cho
NPI 1750360822
$3,292.42
in general payments reported to CMS, 2019-2025
26 companies · $815 in 2025
The $815 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $190 · 2021: $297 · 2022: $286 · 2023: $907 · 2024: $525 · 2025: $815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,247.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $590.89 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $490.13 | 2020-2024 | Camzyos, Eliquis |
| Medtronic, INC. | $356.38 | 2021-2025 | Linq II, Spiderfx |
| Abbott Laboratories | $303.43 | 2019-2024 | Epic |
| Novartis Pharmaceuticals Corporation | $298.74 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $187.80 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $162.67 | 2019-2025 | Lifevest |
| Pfizer INC. | $159.45 | 2021-2025 | |
| Inspire Medical Systems, INC. | $114.45 | 2023 | Inspire |
| United Therapeutics Corporation | $101.25 | 2025 | |
| Amgen INC. | $100.09 | 2019-2022 | |
| Amarin Pharma, INC. | $82.24 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $49.21 | 2020-2023 | |
| Medicomp INC | $36.29 | 2023 | Telepatch Cardiac Monitor |
| W. L. Gore & Associates, INC. | $35.32 | 2025 | Gore Viabahn Endoprosthesis With Heparin |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $30.03 | 2021-2022 | |
| Boston Scientific Corporation | $26.76 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Bracco Diagnostics INC. | $24.37 | 2025 | |
| Merck Sharp & Dohme LLC | $22.42 | 2023 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $22.23 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.19 | 2020 | |
| Abiomed | $20.43 | 2024 | Impella |
| Impulse Dynamics (USA) INC. | $14.29 | 2023 | Optimizer |
| Philips North America LLC | $14.18 | 2023 | |
| Lundbeck LLC | $14.13 | 2019 | |
| Esperion Therapeutics, INC. | $14.05 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.